Fundraising Fox

Wayfinder Biosciences

5 known investors

Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

JFJason Fontana
Jason FontanainFounder & CEO
DSDavid Sparkman-Yager
David Sparkman-YagerinFounder & CTO
CHChuhern Hwang
Chuhern HwanginFounder & Head of Drug Discovery

Investors · 5

Notation CapitalNew York · $400K – $750K
Social StartsSan Francisco
BoxOne VenturesreportedMontréal · $500K
Divergent CapitalreportedNew York · $250K – $1M
Exor Venturesreported · 2 sources

In the news

SLS Client Wayfinder Biosciences Raises $2.5MM Round from Exor Ventures – Silicon Legal Strategy | Entrepreneurial Legal Counselsiliconlegal.com · Oct 2023Wayfinder Biosciences Raises $3.5M to Program RNA | Life Science Washingtonlifesciencewa.org · Oct 2022

Frequently asked questions

What does Wayfinder Biosciences do?
Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.
Who founded Wayfinder Biosciences?
Wayfinder Biosciences was founded by Jason Fontana, David Sparkman-Yager, Chuhern Hwang.
Who are Wayfinder Biosciences's investors?
Wayfinder Biosciences's investors include Notation Capital, Social Starts, BoxOne Ventures, Divergent Capital, Exor Ventures.